Pharmacological characterization of the nociceptin receptor mediating hyperphagia: Identification of a selective antagonist

Psychopharmacology

Volumn 148, Issue 4, 2000, Pages 430-437

  Polidori, Carlo ^a   Calo', Girolamo ^b   Ciccocioppo, Roberto ^a   Guerrini, Remo ^b   Regoli, Domenico ^b   Massi, Maurizio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Food deprivation; Food intake; Neuropeptide Y; Nociceptin; Orphanin FQ

Indexed keywords

APPETITE STIMULANT; DRUG VEHICLE; NEUROPEPTIDE Y; NOCICEPTIN; NOCICEPTIN RECEPTOR; RECEPTOR BLOCKING AGENT;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LATERAL VENTRICLE; BRAIN THIRD VENTRICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG POTENCY; DRUG SELECTIVITY; FEEDING BEHAVIOR; FOOD DEPRIVATION; FOOD INTAKE; HYPERPHAGIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0001580029     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050073     Document Type: Article

References (44)

1. Angeletti S, Panocka I, Ciccocioppo R, Gini L, Massi M (1999) Effect of nociceptin (NC) on morphine-induced conditioned place preference (CPP) in rats. Regul Pept 80:122
2. Anton B, Fein J, To T, Li X, Silberstein L, Evans CJ (1996) Immunohistochemical localization of ORL1 in the central nervous system of the rat. J Comp Neurol 368:229-251
3. Bigoni R, Giuliani S, Calo' G, Rizzi A, Guerrini R, Salvatori S, Regoli D, Maggi CA (1999) Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. NaunynSchmiedeberg's Arch Pharmacol 359:160-167
4. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M, Grandy DK (1994) Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or kappa opioid receptor type. FEBS Lett 347:284-288
5. 2 is an agonist of the nociceptin (ORL1) receptor. Eur J Pharmacol 349: R5-R6
6. Calo' G, Rizzi A, Bigoni G, Neugebauer W, Salvadori S, Guerrini R, Bianchi C, Regoli D (1996) The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur J Pharmacol 311:R3-R5
7. Calo' G, Rizzi A, Bodin M, Neugebauer W, Salvadori S, Guerrini R, Bianchi C, Regoli D (1997) Pharmacological characterization of nociceptin receptor: an in vitro study. Can J Physiol Pharmacol 75:713-718
8. 2 N-terminal tridecapeptide and discovery of a nociceptin receptor antagonist. J Med Chem 41:3360-3366
9. Calo' G, Rizzi A, Marzola G, Guerrini R, Salvadori S, Beani L, Regoli D, Bianchi C (1998b) Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol 125:373-378
10. 2, a novel selective nociceptin receptor antagonist. In: 1999 INRC Meeting, Saratoga Springs, New York, USA, 10-15 July
11. 2 on nociception in rats. In: 29th International Narcotic Research Conference, A 170, Garmisch-Partenkirchen, Germany, 20-25 July
12. 2]-nociceptin-(1-13)NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord. Br J Pharmacol 125:949-951
13. Chen Y, Fans Y, Liu J, Mestek A, Tian M, Kozak CA, Yu L (1994) Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett 347:279-283
14. Ciccocioppo R, Panocka I, Polidori C, Regoli D, Massi M (1999) Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology 141:220-224
15. Darland T, Heinricher MM, Grandy DK (1998) Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci 21:215-221
16. Devine DP, Taylor L, Reinscheid RK, Monsma FJ Jr, Civelli O, Akil H (1996) Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res 21:1387-1396
17. Fukuda K, Kato S, Mori K, Nishi M, Takeshima H, Iwabe N, Miyata T, Houtani T, Sugimoto T (1994) cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett 343:42-46
18. 2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo. Eur J Pharmacol 357:R1-R3
19. Guerrini R, Calo' G, Rizzi A, Bianchi C, Lawrence HL, Salvadori S, Temussi PA, Regoli D (1997) Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem 40:1789-1793
20. Guerrini R, Calo' G, Rizzi A, Bigoni R, Bianchi C, Salvadori S, Regoli D (1998) A new selective antagonist of the nociceptin receptor. Br J Pharmacol 123:163-165
21. Guerrini R, Calo' G, Bigoni R, Rizzi A, Varani K, Toth G, Gessi S, Borea P, Salvadori S, Regoli D (1999) Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor. Regul Pept 80:124
22. Kapusta DR, Sezen SF, Chang JK, Lippton H, Kenigs VA (1997) Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci 60:15-21
23. Lapalu S, Moisand C, Mazarguil H, Cambois G, Mollereau C, Meunier JC (1997) Comparison of the structure-activity relationships of nociceptin and dynorphin. A using chimeric peptides. FEBS Lett 417: 333-336
24. Madeddu P, Salis MB, Milia AF, Emanueli C, Guerrini R, Regoli D, Calo' G (1999) Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension 33:914-919
25. 2 on ethanol intake and ethanol-induced conditioned place preference (CPP) in alcohol-preferring rats. Regul Pept 80:125
26. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Parmentier M, Costentin J (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377:532-535
27. Mogil JS, Grisel JE, Reinscheid RK. Civelli O, Belknap JK, Grandy DK (1996) Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75:333-337
28. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC (1994). ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341:33-38
29. Murphy NP, Lee Y, Maidment NT (1999) Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res 832:168-170
30. 2 at the ORL1 receptor of central and peripheral sites. In: 29th International Narcotic Research Conference, A 129, Garmisch-Partenkirchen, Germany, 20-25 July
31. 2 in rat brain, vas deferens and CHO cells expressing recombinant human nociceptin receptors. Br J Pharmacol 127:123-130
32. 2 act as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells. Neuroreport 10:1127-1131
33. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, North Ryde, N.S.W., Australia
34. Pohorecky LA, Blakely GG, Benjamin D (1998) Antisense knockdown of ORL-1 receptor results in increased ethanol-induced locomotor activation and attenuation of the circadian rhythm of body temperature and water consumption in rats. Alcohol Clin Exp Res 22:159A
35. Pomonis JD, Billington CJ, Levine AS (1996) Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport 8:369-371
36. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr, Civelli O (1995) Orphanin FQ: neuropeptide that activates an opioid-like G protein-coupled receptor. Science 270:792-794
37. Reinscheid RK, Higelin J, Henningsen RA, Monsma FJJr, Civelli O (1998) Structures that delineate orphanin FQ and dinorphin A pharmacological selectivities. J Biol Chem 273:1490-1495
38. Rizzi A, Calo' G, Trevisani M, Tognetto M, Fabbri L, Guerrini R, Salvadori S, Regoli D, Geppetti P (1999) Nociceptin receptor activation inhibits tachykinergic non-adrenergic noncholinergic contraction of guinea pig isolated bronchus. Life Sci 64:PL157-163
39. Schlicker E, Werthwein S, Kathmann M, Bauer U (1998) Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 358:418-422
40. Shah S, Page CP, Spina D (1998) Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br J Pharmacol 125:510-516
41. Stratford TR, Holahan MR, Kelley AE (1997) Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. Neuroreport 8:423-426
42. Tian JH, Xu W, Fang Y, Mogil JS, Grisel JE, Grandy DK, Han JS (1997) Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br J Pharmacol 120:676-680
43. Toll L, Burnside J, Berzetei-Gurske I (1998) Agonist activity of ORL1 antagonists is dependent upon receptor number. In: International Narcotics Research Conference 1998, Garmisch-Partenkirchen, Germany, 20-25 July, A89
44. 2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci Lett 249:127-130